-
Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research - Part 2
-
PRO Data Collection in Clinical Trials Using Mixed Modes
-
A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making - Report 1
-
Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making - Report 2
-
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling
-
Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data - Recommendations for Clinical Trial Teams
-
Constructing Experimental Designs for Discrete-Choice Experiments
-
Modeling Good Research Practices - Overview: Report 1
-
Conceptualizing a Model: Report 2
-
State-Transition Modeling: Report 3
-
Modeling Using Discrete Event Simulation: Report 4
-
Dynamic Transmission Modeling: Report 5
-
Model Parameter Estimation and Uncertainty Analysis: Report 6
-
Model Transparency and Validation: Report 7
-
Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 1
-
Content Validity – Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 2
-
Conjoint Analysis Applications in Health - A Checklist
-
Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy - Report of ISPOR Risk–Benefit Management Working Group
-
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification
-
Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data
Questions?
For any questions about this report please contact us.